Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Sarcoma 48Lymphoma 34Lymphoma, Large B-Cell, Diffuse 32Lymphoma, Non-Hodgkin 23Osteosarcoma 21Hodgkin Disease 17Testicular Neoplasms 16Burkitt Lymphoma 13Testicular Germ Cell Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Ovarian Neoplasms 12Teratoma 9Neuroectodermal Tumors, Primitive, Peripheral 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Follicular 9Neuroblastoma 8Lymphoma, Large-Cell, Anaplastic 8Central Nervous System Neoplasms 8Recurrence 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell 7Leukemia 7Endodermal Sinus Tumor 7Seminoma 6Rhabdomyosarcoma 6Lymphoma, B-Cell, Marginal Zone 6Breast Neoplasms 6Small Cell Lung Carcinoma 5Neoplasms, Germ Cell and Embryonal 5Neoplasms 5

Interventions

Irinotecan 16Paclitaxel 14Docetaxel 13Gemcitabine 12Cisplatin 12Capecitabine 8Oxaliplatin 7Temozolomide 6Leucovorin 6Fluorouracil 6Carboplatin 6Topotecan 5Chromatography, High Pressure Liquid 5Polymerase Chain Reaction 4Pharmacogenomic Testing 4Pemetrexed 4Immunohistochemistry 4Filgrastim 4Everolimus 4Etoposide 4Early Intervention, Educational 4Celecoxib 4tipifarnib 3ixabepilone 3bryostatin 1 3Tegafur 3Sorafenib 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Lapatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Unspecified Adult Solid Tumor, Protocol Specific × Ifosfamide × Clear all
NCT00003198 2013-06-27

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡